US2015157009A1PendingUtilityA1
Preservation Solutions For Biologics And Methods Related Thereto
Assignee: HEMEMICS BIOTECHNOLOGIES INCPriority: Feb 17, 2010Filed: Feb 13, 2015Published: Jun 11, 2015
Est. expiryFeb 17, 2030(~3.6 yrs left)· nominal 20-yr term from priority
A01N 1/126A01N 1/122A01N 1/021
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions (i.e., preservation solutions) for preserving biologics comprising at least one membrane penetrable sugar, at least one membrane impenetrable sugar, at least one anti-microbial agent, at least one anti-oxidant, adenosine albutinum, a salt, a buffer, and a chelating agent, and to methods of using such preservation solutions to preserve biologies.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled)
18 . A method of preserving a cancer cell comprising:
contacting the cancer cell with a solution, wherein the solution comprises:
a buffer;
from about 0.01% to about 10% salt;
at least one membrane penetrable sugar;
a neutral dextran with a molecular weight greater than or equal to 50,000 daltons; and
0.1% w/v to about 12% w/v glucose; and
drying the cancer cell by room temperature induced dryness.
19 . The method of claim 18 , wherein the buffer is from about 0.1 mg/mL, to about 2.0 mg/mL, phosphate buffer.
20 . The method of claim 18 , wherein the buffer is 0.1 M HEPES.
21 . The method of claim 18 , wherein the salt is from about 0.25% to about 2% NaCl.
22 . The method of claim 18 , wherein the at least one membrane penetrable sugar is trehalose.
23 . The method of claim 22 , wherein trehalose is 0.1% w/v to about 12% w/v.
24 . The method of claim 18 , wherein the neutral dextran with a molecular weight greater than or equal to 50,000 daltons is Dextran-70.
25 . The method of claim 24 , wherein the Dextran-70 is from about 0.01% w/v to about 25% w/v.
26 . The method of claim 24 , wherein the Dextran-70 is 6% w/v.
27 . The method of claim 18 , wherein the glucose is about 2% w/v.
28 . The method of claim 18 , further comprising rehydrating the cancer cell.
29 . The method of claim 18 , wherein:
the buffer is 0.1 M HEPES; the salt is from about 0.25% to about 2% NaCl; the at least one membrane penetrable sugar is 0.1% w/v to about 12% w/v trehalose; the neutral dextran with a molecular weight greater than or equal to 50,000 daltons is from about 0.01% w/v to about 25% w/v Dextran-70; and the glucose is 0.1% w/v to about 12% w/v glucose.
30 . A method of preserving a cancer cell comprising:
contacting the cancer cell with a solution, wherein the solution comprises:
0.1 M HEPES;
from about 0.25% to about 2% NaCl;
0.1%) w/v to about 12%) w/v trehalose;
6% w/v Dextran-70; and
about 2% w/v glucose; and drying the cell at room temperature.Join the waitlist — get patent alerts
Track US2015157009A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.